These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2835090)

  • 1. Binding of cholesterol and inhibitory peptide derivatives with the fusogenic hydrophobic sequence of F-glycoprotein of HVJ (Sendai virus): possible implication in the fusion reaction.
    Asano K; Asano A
    Biochemistry; 1988 Feb; 27(4):1321-9. PubMed ID: 2835090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is a specific amino acid sequence of F glycoprotein required for the membrane fusion reaction between envelope of HVJ (Sendai virus) and target cell membranes?
    Asano K; Asano A
    Biochem Int; 1985 Jan; 10(1):115-22. PubMed ID: 2985082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition.
    Ghosh JK; Peisajovich SG; Shai Y
    Biochemistry; 2000 Sep; 39(38):11581-92. PubMed ID: 10995225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements for hemolytic activity of F-glycoprotein of HVJ (Sendai virus) studied by proteolytic dissection.
    Asano K; Murachi T; Asano A
    J Biochem; 1983 Mar; 93(3):733-41. PubMed ID: 6307987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral proteins in cell fusion.
    Asano A; Asano K
    Tokai J Exp Clin Med; 1982; 7 Suppl():193-6. PubMed ID: 6310822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein.
    Dallocchio F; Tomasi M; Bellini T
    Biochem Biophys Res Commun; 1994 Jun; 201(2):988-93. PubMed ID: 8003040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple lipid interactions of the Sendai virus fusogenic protein.
    Moscufo N; Gallina A; Schiavo G; Montecucco C; Tomasi M
    J Biol Chem; 1987 Aug; 262(24):11490-6. PubMed ID: 3040704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of Sendai virions or reconstituted Sendai virus envelopes with liposomes or erythrocyte membranes lacking virus receptors.
    Citovsky V; Loyter A
    J Biol Chem; 1985 Oct; 260(22):12072-7. PubMed ID: 2995357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes.
    Rapaport D; Shai Y
    J Biol Chem; 1994 May; 269(21):15124-31. PubMed ID: 8195149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Sendai virus fusion with phospholipid vesicles and human erythrocyte membranes by hydrophobic peptides.
    Kelsey DR; Flanagan TD; Young JE; Yeagle PL
    Virology; 1991 Jun; 182(2):690-702. PubMed ID: 1850923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane vesicles containing the Sendai virus binding glycoprotein, but not the viral fusion protein, fuse with phosphatidylserine liposomes at low pH.
    Chejanovsky N; Zakai N; Amselem S; Barenholz Y; Loyter A
    Biochemistry; 1986 Aug; 25(17):4810-7. PubMed ID: 3021204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses.
    Samuel O; Shai Y
    Biochemistry; 2001 Feb; 40(5):1340-9. PubMed ID: 11170461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein blot analysis of virus receptors: identification and characterization of the Sendai virus receptor.
    Gershoni JM; Lapidot M; Zakai N; Loyter A
    Biochim Biophys Acta; 1986 Mar; 856(1):19-26. PubMed ID: 3006771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of fluorescence photobleaching recovery to assess complex formation between the two envelope proteins of Sendai virus in membranes of fused human erythrocytes.
    Katzir Z; Gutman O; Henis YI
    Biochemistry; 1989 Jul; 28(15):6400-5. PubMed ID: 2551371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody against the carboxyl terminus of the F2 subunit of Sendai virus fusion glycoprotein inhibits proteolytic activation.
    Tashiro M; Takeda M; Tanaka S; Nishimura N; Takenaka M; Kido H
    Virology; 1993 Jun; 194(2):882-5. PubMed ID: 8389088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Sendai virus fusion protein by receptor binding.
    Dallocchio F; Tomasi M; Bellini T
    Biochem Biophys Res Commun; 1995 Mar; 208(1):36-41. PubMed ID: 7887950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the fusogenic properties of Sendai virus: kinetics of fusion with erythrocyte membranes.
    Hoekstra D; Klappe K; de Boer T; Wilschut J
    Biochemistry; 1985 Aug; 24(18):4739-45. PubMed ID: 3000417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of membrane fusion efficiency and its use for distinguishing epitopes on the fusion (F) protein of Sendai virus (HVJ).
    Miura N; Soe G; Uchida T; Okada Y
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1051-7. PubMed ID: 7688959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmotic swelling allows fusion of sendai virions with membranes of desialyzed erythrocytes and chromaffin granules.
    Citovsky V; Laster Y; Schuldiner S; Loyter A
    Biochemistry; 1987 Jun; 26(13):3856-64. PubMed ID: 2820480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation.
    Gething MJ; White JM; Waterfield MD
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2737-40. PubMed ID: 208074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.